Literature DB >> 25960221

Anti-fibrotic effect of trans-resveratrol on pancreatic stellate cells.

Siu Wai Tsang1, Hongjie Zhang2, Zesi Lin3, Huaixue Mu2, Zhao-Xiang Bian4.   

Abstract

Trans-resveratrol, also known as 3,5,4'-trihydroxy-trans-stilbene, is a natural stilbenoid found at high concentration in skins of red grapes and berries. Over the recent years, it has been reported with a variety of beneficial effects such as antioxidant, anti-aging and anti-inflammatory bioactivities; thus often utilized as an active substance in human and veterinary therapeutics. In the current study, we aimed to delineate the mechanism of its anti-fibrotic action by means of various biochemical assays, such as immunofluorescent staining, real-time polymerase chain reaction and Western blotting analyses in a cellular model, the LTC-14 cells, which retain essential characteristics and morphological features of primary pancreatic stellate cells (PSCs). Our results demonstrated that the application of trans-resveratrol as low as 10 μM notably suppressed the mRNA and protein levels of different fibrotic mediators namely alpha-smooth muscle actin, type I collagen and fibronectin in the LTC-14 cells stimulated with transforming growth factor-beta, a well recognized pro-fibrotic inducer. Importantly, the mechanism of the anti-fibrotic action of trans-resveratrol was associated with a decrease in nuclear factor-kappaB activation and protein kinase B phosphorylation. In conclusion, our finding suggests that trans-resveratrol may serve as a therapeutic or an adjuvant agent in anti-fibrotic approaches and/or PSC-relating pathologies.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-fibrotic agent; Pancreatic fibrosis; Pancreatic stellate cells; Resveratrol; Trans-resveratrol

Mesh:

Substances:

Year:  2015        PMID: 25960221     DOI: 10.1016/j.biopha.2015.02.013

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

Review 1.  Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-23

2.  An innovative biotransformation to produce resveratrol by Bacillus safensis.

Authors:  Xiaoyan Hu; Yexue Liu; Dengke Li; Wei Feng; Hanmeng Ni; Shan Cao; Fuping Lu; Yu Li
Journal:  RSC Adv       Date:  2019-05-17       Impact factor: 4.036

Review 3.  Pancreatic stellate cell: Pandora's box for pancreatic disease biology.

Authors:  Ratnakar R Bynigeri; Aparna Jakkampudi; Ramaiah Jangala; Chivukula Subramanyam; Mitnala Sasikala; G Venkat Rao; D Nageshwar Reddy; Rupjyoti Talukdar
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

4.  Sinonasal Delivery of Resveratrol via Mucoadhesive Nanostructured Microparticles in a Nasal Polyp Mouse Model.

Authors:  Mingyu Lee; Chun Gwon Park; Beom Kang Huh; Se-Na Kim; Seung Ho Lee; Roza Khalmuratova; Jong-Wan Park; Hyun-Woo Shin; Young Bin Choy
Journal:  Sci Rep       Date:  2017-01-10       Impact factor: 4.379

5.  Resveratrol Inhibits ROS-Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR-21.

Authors:  Bin Yan; Liang Cheng; Zhengdong Jiang; Ke Chen; Cancan Zhou; Liankang Sun; Junyu Cao; Weikun Qian; Jie Li; Tao Shan; Jianjun Lei; Qingyong Ma; Jiguang Ma
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

6.  Anti-fibrotic effects of phenolic compounds on pancreatic stellate cells.

Authors:  Zesi Lin; Lu-Cong Zheng; Hong-Jie Zhang; Siu Wai Tsang; Zhao-Xiang Bian
Journal:  BMC Complement Altern Med       Date:  2015-07-30       Impact factor: 3.659

7.  Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitis.

Authors:  Siu Wai Tsang; Yi-Fu Guan; Juan Wang; Zhao-Xiang Bian; Hong-Jie Zhang
Journal:  Sci Rep       Date:  2016-03-14       Impact factor: 4.379

8.  Resveratrol-Mediated Repression and Reversion of Prostatic Myofibroblast Phenoconversion.

Authors:  Mehrnaz Gharaee-Kermani; Bethany B Moore; Jill A Macoska
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

9.  Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation.

Authors:  Ying Xiao; Tao Qin; Liankang Sun; Weikun Qian; Jie Li; Wanxing Duan; Jianjun Lei; Zheng Wang; Jiguang Ma; Xuqi Li; Qingyong Ma; Qinhong Xu
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.